Inovio Pharmaceuticals
INO
$12.01
Share price
3.62%
Change (1 day)
1,501.33%
Change (1 year)
Categories
Inovio Pharmaceuticals (INO) - Total debt
Total debt on the balance sheet as of December 2023 : $30.2 M
According to Inovio Pharmaceuticals's latest financial reports the company's total debt is $30.2 M. A company’s total debt is the sum of all current and non-current debts.
Inovio Pharmaceuticals - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $30.2 M | -5.82% |
| 2022-12-31 | $32.07 M | -2.87% |
| 2021-12-31 | $33.02 M | -15.43% |
| 2020-12-31 | $39.04 M | -60.76% |
| 2019-12-31 | $99.5 M | |
| 2018-12-31 | $N/A | |
| 2010-12-31 | $N/A | -100% |
| 2009-12-31 | $12.11 M | 0.04% |
| 2008-12-31 | $12.1 M | |
| 2003-12-31 | $0.33 M | 1504.32% |
| 2002-12-31 | $0.02 M | -57.1% |
| 2001-12-31 | $0.04 M | |
| 2001-03-31 | $0.11 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 96,996.25% | 🇺🇸 USA |
 Novartis NVS | $27.28 B | 90,216.86% | 🇨🇭 Switzerland |
 Pfizer PFE | $70.84 B | 234,414.65% | 🇺🇸 USA |
 Gilead Sciences GILD | $24.98 B | 82,613.21% | 🇺🇸 USA |
 Merck MRK | $35.05 B | 115,940.81% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $22.93 B | 75,826.87% | 🇬🇧 UK |
 Cleveland BioLabs
CBLI | N/A | N/A | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | $0.11 B | 292.52% | 🇺🇸 USA |